Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Flowers
Hyde, Homer
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.
FDG-PET/CT findings of a metastatic pituitary tumor.
MET as a possible target for non-small-cell lung cancer.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET as a possible target for non-small-cell lung cancer.
MET as a possible target for non-small-cell lung cancer. J Clin Oncol. 2013 Mar 10; 31(8):1089-96.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Hepatocyte Growth Factor
Humans
Lung Neoplasms
Mutation
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia